Antibody-Drug Conjugates

The 21st Century Magic Bullets for Cancer

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Antibody-Drug Conjugates by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319130811
Publisher: Springer International Publishing Publication: March 5, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319130811
Publisher: Springer International Publishing
Publication: March 5, 2015
Imprint: Springer
Language: English

This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.

More books from Springer International Publishing

Cover of the book Elliptic Integrals, Elliptic Functions and Modular Forms in Quantum Field Theory by
Cover of the book Optimized Packings with Applications by
Cover of the book Timing Performance of Nanometer Digital Circuits Under Process Variations by
Cover of the book Materials Design and Applications by
Cover of the book Fractional-Order Devices by
Cover of the book Computer Networks by
Cover of the book Saphenous Vein-Sparing Strategies in Chronic Venous Disease by
Cover of the book Non-equilibrium Evaporation and Condensation Processes by
Cover of the book Antibacterials by
Cover of the book A Doctorate and Beyond by
Cover of the book The Keynesian Revolution and Our Empty Economy by
Cover of the book Advanced Intelligent Systems for Sustainable Development (AI2SD’2018) by
Cover of the book Novel Sensors for Food Inspection: Modelling, Fabrication and Experimentation by
Cover of the book Ethics and Science Education: How Subjectivity Matters by
Cover of the book Mitochondrial Biology and Experimental Therapeutics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy